₹ 1,597.90
84.30 (5.57%)
S
Symbiotec Pharmalab
₹ 1,597.90
Symbiotec Pharmalab Fundamentals
Company Valuation
Market Cap (₹ Cr.)
10,267
PE Ratio
76.90
PB Ratio
7.15
Dividend Yield
-
ROE
9.56%
ROCE
14.26%
Book Value (₹)
211.80
Face Value (₹)
2.00
Analyse SYMBIOTEC with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Aug 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 35.07% | 33.28% | 33.28% |
| Domestic Institutional Investors (DII) | 0.00% | 27.52% | 33.17% |
| Foreign Institutional Investors (FII) | 0.00% | 21.08% | 3.79% |
| Public Investors | 0.00% | 16.60% | 7.81% |
| Government | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
SYMBIOTEC Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Sub Sector
Company Classification
Microcap
BSE Scrip Code
544889
NSE Scrip Name
SYMBIOTEC
ISIN
INE899I01028
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

